Clinical outcome after 4 years follow-up of HIV-seropositive subjects with incomplete virologic or immunologic response to HAART
about
Increased bone marrow interleukin-7 (IL-7)/IL-7R levels but reduced IL-7 responsiveness in HIV-positive patients lacking CD4+ gain on antiviral therapyPredictors of suboptimal CD4 response among women achieving virologic suppression in a randomized antiretroviral treatment trial, Africa.Predictors of immunological failure of antiretroviral therapy among HIV infected patients in Ethiopia: a matched case-control studyDiscordant Immune Response with Antiretroviral Therapy in HIV-1: A Systematic Review of Clinical Outcomes.The absence of CD4+ T cell count recovery despite receipt of virologically suppressive highly active antiretroviral therapy: clinical risk, immunological gaps, and therapeutic options.Polyactin A increases CD4(+) T-cell counts in HIV-infected individuals with insufficient immunologic response to highly active antiretroviral therapy.Prevalence of discordant immunologic and virologic responses in patients with AIDS under antiretroviral therapy in a specialized care center in Brazil.Add-on Pyridostigmine Enhances CD4+ T-Cell Recovery in HIV-1-Infected Immunological Non-Responders: A Proof-of-Concept Study.Polyactin A can increase CD4+T cell counts in HIV-infected individuals with insufficient immunologic response to HAART: is it a reality?
P2860
Q33786846-25114864-073F-4BDC-B3DF-BDF3E12C36FFQ33850736-47FEB2CE-50B1-4FD6-B7DA-C066741BFAA0Q34764695-B4CA0C22-6E77-4B4C-9BFE-42ACCEAC80BEQ36047903-21B7720F-E3AF-4C65-AD45-8F192D37380BQ37362435-7244A548-C69D-48E3-9CCE-0FE2FFDBB26FQ42274775-5F76C3A0-06BF-472F-A31E-A43F2DB4C489Q44120477-6A8EFF74-465D-4668-BCEF-07368B40617FQ47138708-0DC1E193-8D78-4FD5-B808-2B904D64072BQ51804081-778933F9-BFDE-4064-8E0D-268D77875CEB
P2860
Clinical outcome after 4 years follow-up of HIV-seropositive subjects with incomplete virologic or immunologic response to HAART
description
article
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2005
@uk
name
Clinical outcome after 4 years ...... immunologic response to HAART
@en
Clinical outcome after 4 years ...... immunologic response to HAART
@nl
type
label
Clinical outcome after 4 years ...... immunologic response to HAART
@en
Clinical outcome after 4 years ...... immunologic response to HAART
@nl
prefLabel
Clinical outcome after 4 years ...... immunologic response to HAART
@en
Clinical outcome after 4 years ...... immunologic response to HAART
@nl
P2093
P50
P356
P1476
Clinical outcome after 4 years ...... immunologic response to HAART
@en
P2093
Andrea Geraci
Claudio Angeletti
Italian Antiretroviral Treatment Group (IATG)
Lucia Palmisano
Stefano Vella
P304
P356
10.1002/JMV.20352
P577
2005-06-01T00:00:00Z